Evidence map›Paper›PMID 33642439›Full record

ArticleJournal of atherosclerosis and thrombosis2022

A Resuscitated Case of Acute Myocardial Infarction with both Familial Hypercholesterolemia Phenotype Caused by Possibly Oligogenic Variants of the PCSK9 and ABCG5 Genes and Type I CD36 Deficiency.

Ryo Nishikawa, Masato Furuhashi, Mika Hori, Masatsune Ogura, Mariko Harada-Shiba, Takeshi Okada, Masahiro Koseki, Takeshi Kujiraoka, Hiroaki Hattori, Ryosuke Ito and 3 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Journal of atherosclerosis and thrombosis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Ryo NishikawaDepartment of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine.
Masato FuruhashiDepartment of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine.
Mika HoriDepartment of Molecular Innovation in Lipidology, National Cerebral & Cardiovascular Center Research Institute.
Masatsune OguraDepartment of Molecular Innovation in Lipidology, National Cerebral & Cardiovascular Center Research Institute.
Mariko Harada-ShibaDepartment of Molecular Innovation in Lipidology, National Cerebral & Cardiovascular Center Research Institute.
Takeshi OkadaDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine.
Masahiro KosekiDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine.
Takeshi KujiraokaResearch Department, R&D Center, BML.
Hiroaki HattoriResearch Department, R&D Center, BML.
Ryosuke ItoDepartment of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine.
Atsuko MuranakaDepartment of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine.
Nobuaki KokubuDepartment of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine.
Tetsuji MiuraDepartment of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine.
Sapporo Medical University · JPNational Cerebral and Cardiovascular Center · JPBarnard Microsystems (United Kingdom) · GBOsaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 56-year-old postmenopausal woman with out-of-hospital cardiac arrest caused by acute myocardial infraction was successfully resuscitated by intensive treatments and recovered without any neurological disability. She was diagnosed as having familial hypercholesterolemia (FH) based on a markedly elevated low-density lipoprotein cholesterol (LDL-C) level and family history of premature coronary artery disease. Genetic testing in her family members showed that a variant of the proprotein convertase subtilisin/kexin type 9 (PCSK9) gene (c.2004C>A, p.S668R), which had been previously reported as having uncertain significance, was associated with FH, indicating that the variant is a potential candidate for the FH phenotype. Next-generation sequencing analysis for the proband also showed that there was a heterozygous mutation of the ATP-binding cassette sub-family G member 5 ( ABCG5) gene (c.1166G>A, R389H), which has been reported to increase LDL-C level and the risk of cardiovascular disease. She was also diagnosed as having type 1 CD36 deficiency based on a lack of myocardial uptake of

Indexed as

Hyperlipoproteinemia Type IIMyocardial InfarctionATP Binding Cassette Transporter, Subfamily G, Member 5Blood Platelet DisordersFemaleGenetic Diseases, InbornHumansLipoproteinsMiddle AgedPhenotypeProprotein Convertase 9Receptors, LDLABCG5 protein, humanATP Binding Cassette Transporter, Subfamily G, Member 5LipoproteinsPCSK9 protein, humanProprotein Convertase 9Receptors, LDLABCG5CD36 deficiencyFamilial hypercholesterolemiaPCSK9

Identifiers

PMID33642439
PMCPMC9090482
OpenAlexW3135856426

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.